low healthUNVERIFIED
STAT+: Five biotech updates to read after ESMO this weekend
🕐 10h ago·1 outlet
Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel.
How sure are we
1 outlet
Only one outlet so far: treat it as unconfirmed. That doesn’t make it false; it may be new, or an exclusive.
Who reported it
This report
View original source →Verification Log
No verification data yet
Checks run automatically as new sources are ingested.
Reliability
Reliability ScoreVery high
91%Independent outlets1
Statusnot yet verified
AI checknone yet
Community flags0
Score bands
Very high80–100%
A highly rated outlet, or several independent outletsHigh60–79%
One well-rated outlet so farModerate40–59%
A lower-rated or state-run outlet, or one report of something seriousLow20–39%
A low-rated outlet on a serious or sensitive storyVery low0–19%
Treat it as unconfirmedWhat moves the score
◎
Outlet ratingThe outlet’s rating in WorldPulse’s list of sources starts the score
⇄
Independent outletsEach further outlet that reports the story closes 40% of the gap to 98%
±
Report detailsA few points either way: a summary and a place add a little; state-run outlets on conflict, politics or security, and single reports marked high or critical, lose some
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this
Risk Score
low risk